CompletedNot Applicable

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Japan1,164 participantsStarted 2019-01-15

Plain-language summary

Study objectives is to investigate the safety of long-term daily use of TRADIANCE® Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Japanese patients with Type 2 Diabetes mellitus (T2DM) who are prescribed with TRADIANCE® Combination Tablets AP or BP * Patients who have never been treated with TRADIANCE® Combination Tablets AP or BP before enrolment Exclusion Criteria: None

What they're measuring

Number of Participants With Adverse Drug Reactions (ADRs)

Timeframe: From first dose of study medication until last dose + 7 days, up to 102.1 weeks.

Trial details

NCT IDNCT03761797

SponsorBoehringer Ingelheim

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-03-10

Results submitted2022-04-20

View on ClinicalTrials.gov More Diabetes Mellitus, Type 2 trials